Omeros Corporation (OMER) Stock Forecast

NASDAQ: OMERAnalyst ratings, price target and estimates.

OMER analyst forecast

as of October 18, 2026
Analyst consensus
Buy
4.33 / 5 from 3 analysts
Price target
$27.50
average of analyst targets
Upside to target
+69.8%
from the latest close
Next earnings
November 12, 2026
EPS estimate $-0.05
52-week range
$6.28 – $21.05

OMER analyst ratings

3 analysts
Strong buy
267%
Buy
00%
Hold
133%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

OMER price target

Price $16.20Target $27.50
52-week low $6.2852-week high $21.05

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

OMER earnings per share estimates

Omeros Corporation EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.02−$0.05$0.01−$0.32+93.8%2
Current fiscal year (2026)$0.69$0.50$0.88$2.10−67.1%2
Next fiscal year (2027)$1.23$0.24$2.22$0.69+78.3%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

OMER revenue estimates

Omeros Corporation revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$37.3M$30.9M$40.6M0.0%3
Current fiscal year (2026)$127.5M$103.1M$151.1M0.0%3
Next fiscal year (2027)$221.3M$191.2M$274.3M+73.6%3

OMER EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

OMER revenue: reported and forecast

Reported revenueEstimate (average; low–high)

OMER EPS estimate revisions

Omeros Corporation EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.27−$0.03−$0.03−$0.02−$0.02−92.6%1 up · 0 down
Current fiscal year (2026)$0.38$0.66$0.66$0.69$0.69+81.6%1 up · 0 down
Next fiscal year (2027)−$0.15$1.15$1.15$1.23$1.23−893.5%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

OMER earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; OMER beat in 7 of 12.

What analysts expect from OMER

3 analysts cover Omeros; their consensus rating is buy (4.33 on a 1–5 scale, where 5 is a strong buy). The average price target is $27.50, 69.8% above the latest close of $16.20. Analysts expect earnings of $0.69 per share for 2026, −67.1% from a year earlier. For 2027 the average estimate is $1.23 per share on revenue of $221.3 million. Omeros beat the EPS estimate in 7 of the last 12 quarters.

Related: OMER income statement, OMER key metrics, OMER chart. See the OMER stock overview for the latest quote and news.

OMER forecast FAQ

What is Omeros's price target?

The average analyst price target for Omeros is $27.50, 69.8% above the latest close of $16.20.

Is Omeros a buy, hold or sell?

Of 3 analysts covering Omeros, 2 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Omeros's EPS forecast?

Analysts forecast $0.69 per share for 2026 (range $0.50 to $0.88); for 2027 the estimate is $1.23.

What is Omeros's revenue forecast?

The average revenue estimate for 2026 is $127.5 million, growth of 0.0%; for 2027 it is $221.3 million.

When does Omeros report earnings?

Omeros is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $-0.05.

Does Omeros usually beat earnings estimates?

Omeros reported EPS at or above the analyst estimate in 7 of the last 12 quarters.

Biotechnology: forecast